List of Tables
    Table 1. Congenital Heart Disease Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Congenital Heart Disease Treatment Market Trends
    Table 3. Congenital Heart Disease Treatment Market Drivers
    Table 4. Congenital Heart Disease Treatment Market Challenges
    Table 5. Congenital Heart Disease Treatment Market Restraints
    Table 6. Global Congenital Heart Disease Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Congenital Heart Disease Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Congenital Heart Disease Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Congenital Heart Disease Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Congenital Heart Disease Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Congenital Heart Disease Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Congenital Heart Disease Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Congenital Heart Disease Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Congenital Heart Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Congenital Heart Disease Treatment as of 2021)
    Table 15. Top Players of Congenital Heart Disease Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Congenital Heart Disease Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Congenital Heart Disease Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Congenital Heart Disease Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Congenital Heart Disease Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Congenital Heart Disease Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Congenital Heart Disease Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Congenital Heart Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Congenital Heart Disease Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Congenital Heart Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Congenital Heart Disease Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Congenital Heart Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Congenital Heart Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Congenital Heart Disease Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Pfizer Company Details
    Table 31. Pfizer Business Overview
    Table 32. Pfizer Congenital Heart Disease Treatment Product
    Table 33. Pfizer Revenue in Congenital Heart Disease Treatment Business (2017-2022) & (US$ Million)
    Table 34. Pfizer Recent Development
    Table 35. Novartis Company Details
    Table 36. Novartis Business Overview
    Table 37. Novartis Congenital Heart Disease Treatment Product
    Table 38. Novartis Revenue in Congenital Heart Disease Treatment Business (2017-2022) & (US$ Million)
    Table 39. Novartis Recent Development
    Table 40. Abbott Laboratories Company Details
    Table 41. Abbott Laboratories Business Overview
    Table 42. Abbott Laboratories Congenital Heart Disease Treatment Product
    Table 43. Abbott Laboratories Revenue in Congenital Heart Disease Treatment Business (2017-2022) & (US$ Million)
    Table 44. Abbott Laboratories Recent Development
    Table 45. Roche Company Details
    Table 46. Roche Business Overview
    Table 47. Roche Congenital Heart Disease Treatment Product
    Table 48. Roche Revenue in Congenital Heart Disease Treatment Business (2017-2022) & (US$ Million)
    Table 49. Roche Recent Development
    Table 50. GSK Company Details
    Table 51. GSK Business Overview
    Table 52. GSK Congenital Heart Disease Treatment Product
    Table 53. GSK Revenue in Congenital Heart Disease Treatment Business (2017-2022) & (US$ Million)
    Table 54. GSK Recent Development
    Table 55. Sanofi Company Details
    Table 56. Sanofi Business Overview
    Table 57. Sanofi Congenital Heart Disease Treatment Product
    Table 58. Sanofi Revenue in Congenital Heart Disease Treatment Business (2017-2022) & (US$ Million)
    Table 59. Sanofi Recent Development
    Table 60. Johnson & Johnson Company Details
    Table 61. Johnson & Johnson Business Overview
    Table 62. Johnson & Johnson Congenital Heart Disease Treatment Product
    Table 63. Johnson & Johnson Revenue in Congenital Heart Disease Treatment Business (2017-2022) & (US$ Million)
    Table 64. Johnson & Johnson Recent Development
    Table 65. Medtronic Company Details
    Table 66. Medtronic Business Overview
    Table 67. Medtronic Congenital Heart Disease Treatment Product
    Table 68. Medtronic Revenue in Congenital Heart Disease Treatment Business (2017-2022) & (US$ Million)
    Table 69. Medtronic Recent Development
    Table 70. BD Company Details
    Table 71. BD Business Overview
    Table 72. BD Congenital Heart Disease Treatment Product
    Table 73. BD Revenue in Congenital Heart Disease Treatment Business (2017-2022) & (US$ Million)
    Table 74. BD Recent Development
    Table 75. Boston Scientific Company Details
    Table 76. Boston Scientific Business Overview
    Table 77. Boston Scientific Congenital Heart Disease Treatment Product
    Table 78. Boston Scientific Revenue in Congenital Heart Disease Treatment Business (2017-2022) & (US$ Million)
    Table 79. Boston Scientific Recent Development
    Table 80. Merck Company Details
    Table 81. Merck Business Overview
    Table 82. Merck Congenital Heart Disease Treatment Product
    Table 83. Merck Revenue in Congenital Heart Disease Treatment Business (2017-2022) & (US$ Million)
    Table 84. Merck Recent Development
    Table 85. Eli Lilly Company Details
    Table 86. Eli Lilly Business Overview
    Table 87. Eli Lilly Congenital Heart Disease Treatment Product
    Table 88. Eli Lilly Revenue in Congenital Heart Disease Treatment Business (2017-2022) & (US$ Million)
    Table 89. Eli Lilly Recent Development
    Table 90. Mylan Company Details
    Table 91. Mylan Business Overview
    Table 92. Mylan Congenital Heart Disease Treatment Product
    Table 93. Mylan Revenue in Congenital Heart Disease Treatment Business (2017-2022) & (US$ Million)
    Table 94. Mylan Recent Development
    Table 95. Sun Pharmaceutical Company Details
    Table 96. Sun Pharmaceutical Business Overview
    Table 97. Sun Pharmaceutical Congenital Heart Disease Treatment Product
    Table 98. Sun Pharmaceutical Revenue in Congenital Heart Disease Treatment Business (2017-2022) & (US$ Million)
    Table 99. Sun Pharmaceutical Recent Development
    Table 100. AstraZeneca Company Details
    Table 101. AstraZeneca Business Overview
    Table 102. AstraZeneca Congenital Heart Disease Treatment Product
    Table 103. AstraZeneca Revenue in Congenital Heart Disease Treatment Business (2017-2022) & (US$ Million)
    Table 104. AstraZeneca Recent Development
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
List of Figures
    Figure 1. Congenital Heart Disease Treatment Product Picture
    Figure 2. Global Congenital Heart Disease Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Congenital Heart Disease Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Congenital Heart Disease Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Congenital Heart Disease Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Congenital Heart Disease Treatment Market Share in Global 2017-2028
    Figure 7. Congenital Heart Disease Treatment Report Years Considered
    Figure 8. Product Picture of Medication
    Figure 9. Product Picture of Surgical Therapy
    Figure 10. Global Congenital Heart Disease Treatment Market Share by Type in 2022 & 2028
    Figure 11. Global Congenital Heart Disease Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Congenital Heart Disease Treatment Market Share by Type (2017-2028)
    Figure 13. United States Congenital Heart Disease Treatment Market Share by Type in 2022 & 2028
    Figure 14. United States Congenital Heart Disease Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Congenital Heart Disease Treatment Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospitals and Clinics
    Figure 17. Product Picture of Diagnostic Centers
    Figure 18. Global Congenital Heart Disease Treatment Market Share by Application in 2022 & 2028
    Figure 19. Global Congenital Heart Disease Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 20. Global Congenital Heart Disease Treatment Market Share by Application (2017-2028)
    Figure 21. United States Congenital Heart Disease Treatment Market Share by Application in 2022 & 2028
    Figure 22. United States Congenital Heart Disease Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. United States Congenital Heart Disease Treatment Market Share by Application (2017-2028)
    Figure 24. North America Congenital Heart Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 25. U.S. Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 26. Canada Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Europe Congenital Heart Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. Germany Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. France Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. U.K. Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Italy Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Russia Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Congenital Heart Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. China Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Japan Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. South Korea Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. India Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Australia Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Taiwan Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Indonesia Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Thailand Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Malaysia Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Philippines Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Latin America Congenital Heart Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 45. Mexico Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Brazil Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Argentina Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Congenital Heart Disease Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Turkey Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Saudi Arabia Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.A.E Congenital Heart Disease Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Pfizer Revenue Growth Rate in Congenital Heart Disease Treatment Business (2017-2022)
    Figure 53. Novartis Revenue Growth Rate in Congenital Heart Disease Treatment Business (2017-2022)
    Figure 54. Abbott Laboratories Revenue Growth Rate in Congenital Heart Disease Treatment Business (2017-2022)
    Figure 55. Roche Revenue Growth Rate in Congenital Heart Disease Treatment Business (2017-2022)
    Figure 56. GSK Revenue Growth Rate in Congenital Heart Disease Treatment Business (2017-2022)
    Figure 57. Sanofi Revenue Growth Rate in Congenital Heart Disease Treatment Business (2017-2022)
    Figure 58. Johnson & Johnson Revenue Growth Rate in Congenital Heart Disease Treatment Business (2017-2022)
    Figure 59. Medtronic Revenue Growth Rate in Congenital Heart Disease Treatment Business (2017-2022)
    Figure 60. BD Revenue Growth Rate in Congenital Heart Disease Treatment Business (2017-2022)
    Figure 61. Boston Scientific Revenue Growth Rate in Congenital Heart Disease Treatment Business (2017-2022)
    Figure 62. Merck Revenue Growth Rate in Congenital Heart Disease Treatment Business (2017-2022)
    Figure 63. Eli Lilly Revenue Growth Rate in Congenital Heart Disease Treatment Business (2017-2022)
    Figure 64. Mylan Revenue Growth Rate in Congenital Heart Disease Treatment Business (2017-2022)
    Figure 65. Sun Pharmaceutical Revenue Growth Rate in Congenital Heart Disease Treatment Business (2017-2022)
    Figure 66. AstraZeneca Revenue Growth Rate in Congenital Heart Disease Treatment Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed